You are here

Article info

Article menu

Download PDFPDF

XML
Research Article
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

Authors

  • Madelyn Espinosa-Cotton Free Radical and Radiation Biology Program, Department of Radiation OncologyThe University of Iowa 52242 Iowa City IA USA Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Samuel N. Rodman III Free Radical and Radiation Biology Program, Department of Radiation OncologyThe University of Iowa 52242 Iowa City IA USA Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Kathleen A. Ross Department of Chemical and Biological Engineering, College of EngineeringIowa State University 50011 Ames IA USA Nanovaccine InstituteIowa State University 50011 Ames IA USA PubMed articlesGoogle scholar articles
  • Isaac J. Jensen Interdisciplinary Immunology Graduate ProgramUniversity of Iowa 52242 Iowa City IA USA Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Kenley Sangodeyi-Miller San Jacinto College 77505 Pasadena TX USA PubMed articlesGoogle scholar articles
  • Ayana J. McLaren Lincoln University 19352 Lincoln PA USA PubMed articlesGoogle scholar articles
  • Rachel A. Dahl Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Katherine N. Gibson-Corley Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Adam T. Koch Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Yang-Xin Fu Department of PathologyUT Southwestern Medical Center 75390 Dallas TX USA PubMed articlesGoogle scholar articles
  • Vladimir P. Badovinac Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA Interdisciplinary Immunology Graduate ProgramUniversity of Iowa 52242 Iowa City IA USA Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA Department of Microbiology and ImmunologyUniversity of Iowa 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Douglas Laux Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA Department of Internal Medicine - Hematology, Oncology and Blood and Marrow TransplantationUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Balaji Narasimhan Department of Chemical and Biological Engineering, College of EngineeringIowa State University 50011 Ames IA USA Nanovaccine InstituteIowa State University 50011 Ames IA USA PubMed articlesGoogle scholar articles
  • Andrean L. Simons Free Radical and Radiation Biology Program, Department of Radiation OncologyThe University of Iowa 52242 Iowa City IA USA Holden Comprehensive Cancer CenterUniversity of Iowa Hospitals and Clinics 52242 Iowa City IA USA Nanovaccine InstituteIowa State University 50011 Ames IA USA Department of PathologyUniversity of Iowa 1161 Medical Laboratories 52242 Iowa City IA USA PubMed articlesGoogle scholar articles

Citation

Espinosa-Cotton M, Rodman III SN, Ross KA, et al
Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma
Journal for ImmunoTherapy of Cancer 2019;7:79. doi: 10.1186/s40425-019-0550-z
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.